◆ NeutralAVTRGMEDVCYTWST

Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC

Zacks Investment Research·
Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC

Avantor has expanded its RIM single-use bioprocessing portfolio across the Asia Pacific region with local manufacturing in China. The expansion aims to improve supply reliability and customization for regional biopharma customers. The company's Bioscience & Medtech Products segment showed double-digit order growth and a 1.1x book-to-bill ratio in Q2 2026, supporting long-term bioprocessing growth.

Read Full Article at Zacks Investment Research →
← Back to Financial Intelligence